🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/09/2014 | 56,68 | 57,23 | 56,54 | 56,56 | -0,22% | 1,23% | 9.691.170 |
| 29/09/2014 | 56,33 | 56,98 | 56,12 | 56,69 | +0,03% | 1,54% | 9.137.722 |
| 26/09/2014 | 56,98 | 57,05 | 55,87 | 56,67 | -0,42% | 2,08% | 11.303.938 |
| 25/09/2014 | 57,52 | 57,73 | 56,90 | 56,91 | -1,19% | 1,44% | 9.109.006 |
| 24/09/2014 | 57,55 | 57,77 | 57,47 | 57,60 | +0,13% | 0,51% | 12.015.949 |
| 23/09/2014 | 57,40 | 57,95 | 56,96 | 57,52 | -0,50% | 1,73% | 8.396.681 |
| 22/09/2014 | 57,61 | 58,19 | 57,50 | 57,81 | +0,15% | 1,19% | 9.767.884 |
| 19/09/2014 | 57,97 | 58,10 | 57,72 | 57,72 | +0,30% | 0,66% | 15.175.774 |
| 18/09/2014 | 57,38 | 57,58 | 57,08 | 57,55 | +0,72% | 0,86% | 8.388.297 |
| 17/09/2014 | 56,80 | 57,26 | 56,56 | 57,14 | -0,18% | 1,23% | 10.764.218 |
| 16/09/2014 | 56,78 | 57,31 | 56,56 | 57,24 | +0,79% | 1,31% | 9.479.579 |
| 15/09/2014 | 56,92 | 57,24 | 56,77 | 56,79 | -0,05% | 0,82% | 8.110.367 |
| 12/09/2014 | 57,14 | 57,38 | 56,55 | 56,82 | -0,92% | 1,45% | 7.358.846 |
| 11/09/2014 | 57,45 | 57,67 | 57,07 | 57,35 | -1,09% | 1,05% | 8.158.890 |
| 10/09/2014 | 57,89 | 58,08 | 57,59 | 57,98 | +0,33% | 0,86% | 9.655.014 |
| 09/09/2014 | 58,05 | 58,23 | 57,70 | 57,79 | -0,80% | 0,92% | 7.800.998 |
| 08/09/2014 | 58,42 | 58,52 | 58,04 | 58,25 | -0,21% | 0,82% | 8.824.579 |
| 05/09/2014 | 57,65 | 58,38 | 57,40 | 58,38 | +1,83% | 1,70% | 11.259.922 |
| 04/09/2014 | 57,80 | 58,21 | 57,18 | 57,33 | -0,66% | 1,78% | 11.327.832 |
| 03/09/2014 | 57,37 | 58,07 | 57,31 | 57,71 | +1,15% | 1,33% | 9.532.818 |
| 02/09/2014 | 56,99 | 57,35 | 56,94 | 57,05 | -0,53% | 0,72% | 6.345.116 |
| 29/08/2014 | 57,65 | 57,65 | 57,09 | 57,36 | +0,18% | 0,98% | 5.990.158 |
| 28/08/2014 | 57,15 | 57,47 | 57,10 | 57,25 | -0,46% | 0,65% | 5.492.568 |
| 27/08/2014 | 57,63 | 57,81 | 57,36 | 57,52 | +0,13% | 0,78% | 6.860.942 |
| 26/08/2014 | 56,94 | 57,63 | 56,93 | 57,44 | +0,79% | 1,24% | 9.663.189 |
| 25/08/2014 | 56,62 | 57,13 | 56,55 | 56,99 | +0,95% | 1,03% | 5.418.998 |
| 22/08/2014 | 56,34 | 56,64 | 56,20 | 56,46 | +0,54% | 0,78% | 5.436.605 |
| 21/08/2014 | 56,68 | 56,93 | 56,10 | 56,15 | -1,06% | 1,46% | 8.013.846 |
| 20/08/2014 | 55,99 | 56,84 | 55,85 | 56,76 | +0,97% | 1,77% | 7.376.243 |
| 19/08/2014 | 56,15 | 56,25 | 55,67 | 56,21 | +0,84% | 1,04% | 7.791.880 |